SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Silverman who wrote (209)1/22/1997 10:13:00 PM
From: scaram(o)uche   of 6136
 
Glaxo/Vertex a tough team?

I digress...........

Agouron just licensed Viracept in Europe to their competitor. Are Peter Johnson et al. stupid? No, it is established fact that they are very smart.

So, why did AGPH just license Viracept in Europe to Roche, a company with an approved PI? I've thought of two good answers, one of which would predict that you can take nucleosides and throw the suckers in the trash (for HIV).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News